Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1509-1511
doi: 10.1161/01.ATV.0000036415.04486.01
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thyberg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thyberg, J.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Restenosis
Right arrow Cell biology/structural biology
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1509.)
© 2002 American Heart Association, Inc.


Editorials

Re-endothelialization Via Bone Marrow-Derived Progenitor Cells

Still Another Target of Statins in Vascular Disease

Johan Thyberg

From the Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.

Correspondence to Johan Thyberg, Department of Cell and Molecular Biology, Karolinska Institutet, Box 285, S-17177 Stockholm Sweden. E-mail johan.thyberg@cmb.ki.se


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

According to the response to injury hypothesis presented by Ross and Glomset1 more than 25 years ago, the formation of atherosclerotic plaques is the result of damage to the endothelium. The key steps in this process are: (1) a physical or chemical disruption of the endothelial cell (EC) barrier; (2) platelet adhesion to exposed subendothelial matrix and platelet degranulation; (3) movement of leukocytes (primarily monocytes and T lymphocytes) and plasma constituents into the arterial intima; (4) migration of smooth muscle cells (SMCs) from the media to the intima; and (5) growth in size of the intimal lesions by cell proliferation, deposition of extracellular matrix components, and lipid accumulation (Figure 1). The original model has later been modified continually, among other reasons, to stress that the endothelial damage may have the nature of a functional disturbance rather than a real detachment. This also implies that the relative importance of the above-mentioned steps may differ in different situations.2–4 Nevertheless, the basic concept is still largely the same, and as long as the injurious influence remains, the process will continue and lead to formation of complicated lesions, eventually causing complications such as heart and brain infarction. If, on the other hand, the factors causing a harmful effect on the inner lining of the arteries are removed (eg, hypertension, hyperlipidemia, and smoking), the physical and/or functional integrity of the endothelial cell layer may be restored and the disease halted. An important object in the treatment and prevention of atherosclerosis and other related . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Sho, M. Sho, H. Nanjo, K. Kawamura, H. Masuda, and R. L. Dalman
Hemodynamic Regulation of CD34+ Cell Localization and Differentiation in Experimental Aneurysms
Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1916 - 1921.
[Abstract] [Full Text] [PDF]